~1 spots leftby Apr 2026

Enhancing the Response to Rehabilitation After Stroke Using Repetitive Transcranial Magnetic Stimulation (rTMS)

Recruiting in Palo Alto (17 mi)
LM
Overseen byLisa M Koski, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 2
Waitlist Available
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
No Placebo Group
Prior Safety Data
Approved in 4 Jurisdictions

Trial Summary

What is the purpose of this trial?

Weakness of the arm and hand results in long-term disability for many persons who suffer a stroke. After the initial recovery phase, only limited gains are achieved by retraining the weak limb to perform daily tasks. However, new treatment strategies such as repetitive transcranial magnetic stimulation (rTMS) show promise for enhancing motor recovery after stroke. rTMS is a noninvasive technique for modifying brain activity that aims to improve motor function by correcting abnormal patterns that occur after stroke. We believe that giving rTMS right before a therapy session will prepare the brain so that the patient is better able to participate in and benefit from training of the hand and arm. The goal of this study is to test how well this new strategy works to improve recovery in people who have mild to moderate weakness of the arm and hand after stroke. Participants will receive magnetic stimulation of the movement area of the brain just prior to arm and hand training for a series of eight sessions. We will evaluate changes in hand and arm function after the intervention and one month later to see if the changes are maintained. We will also test whether some groups of people benefit more than others from the intervention. If improvements in hand and arm function are observed after the intervention, we will test it more rigourously in a future clinical trial in which participants are randomly assigned to different treatment conditions. This research will show whether brain stimulation can be used to improve the effectiveness of rehabilitation care.

Research Team

LM

Lisa M Koski, PhD

Principal Investigator

McGill University

Eligibility Criteria

Inclusion Criteria

first clinical stroke involving the middle cerebral artery confirmed by CT or MRI scan during acute care at the MUHC, or second stroke involving the same hemisphere when there were no clinical residual effects from the first stroke;
cortical or subcortical stroke resulting in hemiparesis;
at least 3 months post-stroke;
See 3 more

Treatment Details

Interventions

  • Repetitive Transcranial Magnetic Stimulation (Brain Stimulation)
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Real rTMSExperimental Treatment1 Intervention
Real rTMS - subjects receiving real repetitive TMS - 1Hz over unaffected hemisphere
Group II: Sham rTMSPlacebo Group1 Intervention
Sham rTMS

Repetitive Transcranial Magnetic Stimulation is already approved in Canada for the following indications:

🇨🇦
Approved in Canada as rTMS for:
  • Major depressive disorder
  • Obsessive-compulsive disorder

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
Royal Victoria HospitalMontreal, Canada
Loading ...

Who Is Running the Clinical Trial?

McGill University Health Centre/Research Institute of the McGill University Health Centre

Lead Sponsor

Trials
476
Patients Recruited
170,000+

Canadian Institutes of Health Research (CIHR)

Collaborator

Trials
1417
Patients Recruited
26,550,000+